See more : MMTC Limited (MMTC.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Gongwin Biopharm Holdings Co., Ltd. (6617.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Gongwin Biopharm Holdings Co., Ltd., a leading company in the None industry within the None sector.
You may be interested
- Ashiana Agro Industries Limited (ASHAI.BO) Income Statement Analysis – Financial Results
- Kalyani Steels Limited (KSL.BO) Income Statement Analysis – Financial Results
- New Providence Acquisition Corp. II (NPABW) Income Statement Analysis – Financial Results
- NeuroScientific Biopharmaceuticals Limited (NSB.AX) Income Statement Analysis – Financial Results
- Seychelle Environmental Technologies, Inc. (SYEV) Income Statement Analysis – Financial Results
Gongwin Biopharm Holdings Co., Ltd. (6617.TWO)
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 18.92M | 1.14M | 1.14M | 833.00K | 248.00K |
| Cost of Revenue | 7.72M | 77.00K | 65.00K | 47.00K | 14.00K |
| Gross Profit | 11.20M | 1.07M | 1.08M | 786.00K | 234.00K |
| Gross Profit Ratio | 59.21% | 93.26% | 94.31% | 94.36% | 94.35% |
| Research & Development | 52.65M | 194.32M | 83.05M | 76.26M | 82.52M |
| General & Administrative | 61.63M | 67.43M | 38.85M | 41.89M | 46.54M |
| Selling & Marketing | 30.25M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 91.88M | 67.43M | 38.85M | 41.89M | 46.54M |
| Other Expenses | 0.00 | -35.09M | 4.88M | 13.95M | 0.00 |
| Operating Expenses | 144.53M | 261.75M | 121.90M | 118.15M | 129.06M |
| Cost & Expenses | 152.24M | 261.82M | 121.97M | 118.20M | 129.07M |
| Interest Income | 41.61M | 6.82M | 2.40M | 4.60M | 12.57M |
| Interest Expense | 7.19M | 3.19M | 1.18M | 500.00K | 1.40M |
| Depreciation & Amortization | 13.33M | 13.39M | 12.96M | 12.53M | 5.65M |
| EBITDA | -81.05M | -275.56M | -100.58M | -86.28M | -101.86M |
| EBITDA Ratio | -428.48% | -24,108.66% | -8,799.83% | -10,358.22% | -49,665.73% |
| Operating Income | -133.33M | -288.95M | -113.54M | -98.82M | -128.82M |
| Operating Income Ratio | -704.87% | -25,279.79% | -9,933.51% | -11,862.79% | -51,944.76% |
| Total Other Income/Expenses | 32.15M | -31.45M | 6.11M | 18.05M | 13.50M |
| Income Before Tax | -101.18M | -292.13M | -114.72M | -99.32M | -115.32M |
| Income Before Tax Ratio | -534.89% | -25,558.44% | -10,036.75% | -11,922.81% | -46,499.60% |
| Income Tax Expense | 0.00 | -37.94M | 15.20M | -6.25M | -5.50M |
| Net Income | -92.04M | -254.19M | -121.58M | -93.07M | -109.82M |
| Net Income Ratio | -486.58% | -22,238.76% | -10,637.01% | -11,173.11% | -44,283.87% |
| EPS | -0.81 | -2.29 | -1.10 | -0.88 | -1.07 |
| EPS Diluted | -0.81 | -2.29 | -1.10 | -0.88 | -1.07 |
| Weighted Avg Shares Out | 113.27M | 111.13M | 110.86M | 105.71M | 103.06M |
| Weighted Avg Shares Out (Dil) | 113.27M | 111.13M | 110.86M | 105.71M | 103.06M |
No news found for: 6617.TWO
Source: https://incomestatements.info
Category: Stock Reports